SIM2 and prostate carcinoma: Although SIM2-s expression (as measured by immunohistochemistry of prostatectomy specimens) has been associated with aggressive histopathology in prostate cancer, and overexpressing ectopic SIM2s enhanced survival in certain conditions in PC3AR+ cells [13], [14], the functional role of SIM2 gene in prostate cancer cell is largely unknown.